Acrivon Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 8.34 M | $11.59 M | 0.00% | 21.66% |
| SANDS CAPITAL VENTURES, LLC | 05/08/2026 | 2.12 M | $2.95 M | 0.00% | 5.51% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 888.13 K | $1.23 M | 0.00% | 2.31% |
| ACADIAN ASSET MANAGEMENT LLC | 05/13/2026 | 845.97 K | $1.18 M | 45.55% | 2.20% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 758.44 K | $1.05 M | 19.60% | 1.97% |
| 05/15/2026 | 722.04 K | $1.00 M | 100.00% | 1.88% | |
| MARSHALL WACE, LLP | 05/15/2026 | 560.44 K | $779.01 K | 12.97% | 1.46% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 389.40 K | $541.26 K | -33.44% | 1.01% |
| JANE STREET GROUP, LLC | 05/12/2026 | 239.69 K | $333.17 K | -29.93% | 0.62% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 236.39 K | $328.69 K | 19.26% | 0.61% |
| BLACKROCK, INC. | 05/13/2026 | 208.94 K | $290.43 K | 1.86% | 0.54% |
| GSA CAPITAL PARTNERS LLP | 05/08/2026 | 186.72 K | $260.00 K | 100.00% | 0.48% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 158.90 K | $220.87 K | 270.40% | 0.41% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 107.53 K | $149.47 K | 100.00% | 0.28% |
| STATE STREET CORP | 05/15/2026 | 67.15 K | $93.33 K | 0.00% | 0.17% |
| XTX TOPCO LTD | 05/15/2026 | 66.88 K | $92.97 K | 225.11% | 0.17% |
| NORTHERN TRUST CORP | 05/14/2026 | 48.90 K | $67.97 K | -23.25% | 0.13% |
| MORGAN STANLEY | 05/15/2026 | 36.67 K | $50.97 K | -21.70% | 0.10% |
| UBS GROUP AG | 05/05/2026 | 34.63 K | $48.14 K | -90.06% | 0.09% |
| PANAGORA ASSET MANAGEMENT INC | 05/14/2026 | 33.81 K | $47.00 K | 100.00% | 0.09% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 27.47 K | $38.19 K | 5.01% | 0.07% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 24.02 K | $33.38 K | -49.98% | 0.06% |
| MAREX GROUP PLC | 05/13/2026 | 20.00 K | $27.80 K | 100.00% | 0.05% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 18.36 K | $25.36 K | 0.00% | 0.05% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 16.51 K | $22.95 K | -5.35% | 0.04% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 14.74 K | $20.49 K | -87.66% | 0.04% |
| TWO SIGMA SECURITIES, LLC | 05/15/2026 | 11.68 K | $16.23 K | 100.00% | 0.03% |
| AAF WEALTH MANAGEMENT, LLC | 05/08/2026 | 10.68 K | $14.84 K | 0.00% | 0.03% |
| FMR LLC | 05/15/2026 | 9.42 K | $13.10 K | 9.28% | 0.02% |
| FEDERATED HERMES, INC. | 05/11/2026 | 7.92 K | $11.01 K | 41.20% | 0.02% |
| BARCLAYS PLC | 05/15/2026 | 5.94 K | $8.26 K | -75.66% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 4.53 K | $6.29 K | 100.00% | 0.01% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 4.45 K | $6.19 K | 100.00% | 0.01% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 3.00 K | $4.17 K | 100.00% | 0.01% |
| JPMORGAN CHASE & CO | 05/13/2026 | 638 | $823 | -96.22% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 634 | $881 | 0.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 04/30/2026 | 584 | $812 | 0.00% | 0.00% |
| REDWOOD PARK ADVISORS LLC | 05/04/2026 | 500 | $695 | 0.00% | 0.00% |
| RUSSELL INVESTMENTS GROUP, LTD. | 05/08/2026 | 481 | $669 | 0.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/14/2026 | 400 | $556 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/08/2026 | 326 | $453 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 74 | $103 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 4 | $6 | 100.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Acrivon Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 60 institutional investors and hedge funds held shares of Acrivon Therapeutics Inc. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 8.34 M
Sands Capital Ventures, LLC: 2.12 M
WELLINGTON MANAGEMENT GROUP LLP: 888,130
ACADIAN ASSET MANAGEMENT LLC: 845,973
RENAISSANCE TECHNOLOGIES LLC: 758,440
MARSHALL WACE, LLP: 560,436
42.16% of Acrivon Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 17.61 M shares in the last 24 months. This purchase volume represents approximately $28.18 M in transactions.